KATHRYN GIGUERE: Open Payments
NPI 1972954451 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 47 payments from 13 companies in 2025. Trend: 2023 $1,127 · 2024 $1,146 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $293 |
| E.R. Squibb & Sons, L.L.C. | 17 | $249 |
| AstraZeneca Pharmaceuticals LP | 5 | $125 |
| Edwards Lifesciences Corporation | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Philips North America LLC | 1 | $41 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $23 |
Products named: CAMZYOS, ELIQUIS, SAPIEN 3 Ultra RESILIA, FARXIGA, LEQVIO, VYNDAQEL, NEXLETOL, Extended Holter.
Industry payments across MA — which companies pay providers there.
